Anastasios Makris, Fotios Barkas, Petros P Sfikakis, Evangelos Liberopoulos, Theodosios D Filippatos, Kausik K Ray, Aris P Agouridis. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?Atherosclerosis plus. 2023, 54: 1-6
Edita Pogran, Paul M Haller, Claudia Wegberger, Maximilian Tscharre, Irena Vujasin, Christoph C Kaufmann, Petra Dick, Bernhard Jäger, Johann Wojta, Kurt Huber. The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome.Atherosclerosis plus. 2023, 54: 14-21
Hadjer Namous, Maria Giuseppina Strillacci, Camila Urbano Braz, Dhanu Shanmuganayagam, Christian Krueger, Athanasios Peppas, William C Soffregen, Jess Reed, Juan F Granada, Hasan Khatib. ITGB2 is a central hub-gene associated with inflammation and early fibro-atheroma development in a swine model of atherosclerosis.Atherosclerosis plus. 2023, 54: 30-41
Petri T Kovanen, Alpo Vuorio. SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease.Atherosclerosis plus. 2023, 53: 1-5
Lotta Ulander, Piia Simonen, Heli Tolppanen, Otto Hartman, Tuomas T Rissanen, Kari K Eklund, Marita Kalaoja, Mika Kurkela, Mikko Neuvonen, Mikko Niemi, Janne T Backman, Helena Gylling, Juha Sinisalo, . The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction.Atherosclerosis plus. 2023, 53: 26-32
Winfried März, Nina Schmidt, Ira An Haack, Alexander Dressel, Tanja B Grammer, Marcus E Kleber, Andrea Baessler, F Ulrich Beil, Ioanna Gouni-Berthold, Ulrich Julius, Ursula Kassner, Julius L Katzmann, Gerald Klose, Christel König, Wolfgang Koenig, Ann-Cathrin Koschker, Ulrich Laufs, Martin Merkel, Britta Otte, Klaus G Parhofer, Wibke Hengstenberg, Heribert Schunkert, Ksenija Stach-Jablonski, Elisabeth Steinhagen-Thiessen, Christoph B Olivier, Harry Hahmann, Stefan Krzossok, Anja Vogt, Dirk Mülle. The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainment.Atherosclerosis plus. 2023, 53: 6-15
Sandra Parra, Mireia Saballs, Mark DiNubile, Mireia Feliu, Simona Iftimie, Laia Revuelta, Raul Pavón, Alba Àvila, Susan Levinson, Antoni Castro. Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.Atherosclerosis plus. 2023, 52: 1-8
David Leibowitz, Yuriko Yoshida, Zhezhen Jin, Carlo Mannina, Shunichi Homma, Koki Nakanishi, Mitchell S V Elkind, Tatjana Rundek, Marco R Di Tullio. Long term aortic arch plaque progression in older adults.Atherosclerosis plus. 2023, 52: 18-22
Vivek Krishna Pulakazhi Venu, Annalisa Moregola, Lorenzo Da Dalt, Patrizia Uboldi, Fabrizia Bonacina, Andrés Fernando Muro, Giuseppe Danilo Norata. Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation.Atherosclerosis plus. 2023, 52: 23-31
L Malin Overmars, Joost M Mekke, Wouter W van Solinge, Saskia C A De Jager, Cornelia A R Hulsbergen-Veelken, Imo E Hoefer, Dominique P V de Kleijn, Gert J de Borst, Sander W van der Laan, Saskia Haitjema. Characteristics of peripheral blood cells are independently related to major adverse cardiovascular events after carotid endarterectomy.Atherosclerosis plus. 2023, 52: 32-40